Market closed · data as of 28 Aug 2026 · source NSE via Alphave. Open the live chart →
Entero Healthcare Solutions is one of India's largest organised pharmaceutical distribution companies, consolidating the highly fragmented pharma wholesale market by acquiring regional distributors onto a common technology and supply-chain platform. It distributes medicines and medical products from pharma companies to retail pharmacies and hospitals across India, earning thin distribution margins on high throughput. It listed via IPO in early 2024 and continues to grow through bolt-on distributor acquisitions.
It is among the top few organised pharma distributors in an industry still dominated by small regional wholesalers.
Entero Healthcare Solutions Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Entero Healthcare Solutions Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 26.44 | 21.80 | 10.81 |
| Book value / share (₹) | 402.78 | 406.90 | 377.38 |
| Return on equity | 6.6% | 5.4% | 2.4% |
| Return on capital employed | 11.1% | 7.6% | 5.0% |
| Operating margin | 3.4% | 2.8% | 2.2% |
| Net margin | 2.2% | 2.1% | 1.0% |
| EBITDA | ₹266 Cr | ₹172 Cr | ₹112 Cr |
| Free cash flow | ₹29 Cr | ₹-88 Cr | ₹-42 Cr |
| Total debt | ₹567 Cr | ₹299 Cr | ₹276 Cr |
| Debt to equity | 0.32 | 0.17 | 0.17 |
| Interest coverage | 4.1 | 3.4 | 1.3 |
| Current ratio | 1.58 | 2.46 | 3.34 |
| Shares outstanding | 4,35,11,000 | 4,35,08,000 | 4,34,93,800 |
Open the full income statement, balance sheet and cash flow for ENTERO →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.